Hikma Pharmaceutical reported 22M in Cash and Equivalent for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Artemis Alpha ATS:LN 7.15M 672K
AstraZeneca AZN:LN 5762M 567M
Bayer BAYN:GR € 5785M 1221M
Fresenius FRE:GR € 2077M 1146M
Fresenius Medical Care FMS:US $ 1173.34M 616.82M
Genmab GEN:DC DK 9071M 114M
GlaxoSmithKline GSK:LN 10967M 6693M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 22M 20M
Lonza Group LONN:SW 1.58B 1.08B
Merck MRK:GR € 1339M 560M
Orion ORNBV:FH € 258.7M 42M
Recordati REC:IM € 261.43M 16.85M